![#](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2020/04/michaeljfox-foundation.jpg)
Alpha-synuclein Seed Amplification Assay Program
Expire le 13 septembre 2021
This program supports research that will facilitate integration of alpha-synuclein seed amplification assays into clinical studies for the purposes of predicting prognosis, tracking disease progression and monitoring therapeutic response.